Skip to main content
Log in

Purpurogallin, a scavenger of polymorphonuclear leukocyte-derived oxyradicals

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Purpurogallin (PPG) is a phenolic compound extracted from nutgalls formed on oak trees. It has been used as an additive to edible or nonedible oils or fats, and to hydrocarbon fuels or lubricants to retard their oxidation. We investigated by luminoldependent chemiluminescence (PMNL-CL), the ability of PPG to scavenge oxygen free radicals (OFRs) generated by zymosanactivated polympophonuclear leukocytes (PMNLs). Its OFR-scavenging ability was also investigated by the use of nitro blue tetrazolium (NBT). We also investigated by the dye-exclusion method, if PPG affects the viability of PMNLs. PPG in the concentrations of 0.005–0.4 mM was used in this study. PPG scavenged OFRs produced by zymosan-activated PMNLs in a concentration-dependent manner. Almost complete scavenging was observed at a concentration of 0.2 mM. The NBT test indicated that PPG (0.2 mM) did not completely prevent the activation of PMNLs by zymosan. Viability of PMNLs in the absence or presence of PPG (0.4 mM) were 95.77±0.56% and 96.78±0.60% respectively. The results suggest that PPG scavenges OFRs produced from activated PMNLs in a concentration-dependent manner and that the cell viability is not affected by PPG. PPG is a potent scavenger of OFRs and should be of value in the prevention and treatment of diseases in the pathophysiology of which OFRs are involved. (

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Claus EP: Pharmacognosy 3rd Edition, Lea and Febiger, Philadelphia, pp 231–233, 1965

    Google Scholar 

  2. Critchlow A, Haslam E, Haworth RD, Tinker PB, Waldron NM: The oxidation of some pyrogallol and purpurogallin derivatives. Tetrahedron 23: 2829–2847, 1967

    PubMed  Google Scholar 

  3. Anderson WA: Hydroxylic aromatic compounds as additives for rubber based, composite solid propellants. US Patent 4181545 assigned to United Technologies Corporation, 1980

  4. Wu TW, Wu J, Carey D, Zeng LH: Purpurogallin protects both ventricular myocytes and aortic endothelial cells of rats against oxyradical damage. Biochem Cell Biol 70: 803–809, 1992

    PubMed  Google Scholar 

  5. Wu TW, Zeng LH, Wu J, Carey D: Purpurogallin—a natural and effective hepatoprotectorin vitro andin vivo. Biochem Cell Biol 69: 747–759, 1991

    PubMed  Google Scholar 

  6. Sugiyama H, Fung KP, Wu TW: Purpurogallin as an antioxidant protector of human erythrocytes against lysis by peroxyl radicals. Life Sci 53: 39–43, 1993

    Google Scholar 

  7. Chenoweth DE, Cooper SW, Hugli T, Stewart RW, Blackstone EH, Kirklin JW: Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 304: 497–503, 1981

    PubMed  Google Scholar 

  8. Chiu RCJ, Samson R: Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia and protamine administration. Ann Thorac Surg 37: 229–232, 1984

    PubMed  Google Scholar 

  9. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86: 845–857, 1983

    PubMed  Google Scholar 

  10. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296: 769–774, 1977

    PubMed  Google Scholar 

  11. Lucchesi BR, Werns SW, Fantone JC: The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol 21: 1241–1251, 1989

    PubMed  Google Scholar 

  12. Granger DN: Role of xanthine oxidase and granulocytes in ischemia reperfusion injury. Am J PHysiol 255: H1269–1275, 1988

    PubMed  Google Scholar 

  13. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbern GW: Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 251: H314–322, 1986

    PubMed  Google Scholar 

  14. Fantone JC, Ward PA: Role of oxygen-derived radicals and metabolites in leukocytes-dependent inflammatory reactions. Am J Pathol 107: 397–417, 1982

    Google Scholar 

  15. Babior BM: The respiratory burst of phagocytes. J Clin Invest 73: 599–601, 1984

    PubMed  Google Scholar 

  16. Prasad K, Chaudhary AK, Kalra J: Oxygen-derived free radicals producting activity and survival of activated polymorphonuclear leukocytes. J Mol Cell Biochem 103: 51–62, 1991

    Google Scholar 

  17. Harisson JE, Schultz J: Studies on chlorinating activity of myeloperoxidase. J Biol Chem 251: 1371–1374, 1976

    PubMed  Google Scholar 

  18. Campbell AK, Holt ME, Patel A: Chemiluminescence in medical biochemistry. In: G.M.M. Ablertin and C.P. Price (eds). Recent Advances in Clinical Chemistry, Vol. III. Churchill Livingstone, Edinburgh, 1984, pp 1–30

    Google Scholar 

  19. English D, Andersen BR: Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 5: 249–52, 1974

    PubMed  Google Scholar 

  20. Prasad K, Kalra J, Bharadwaj B, Chaudhary AK: Increased oxygen free radical activity in patients on cardiopuomonary bypass undergoing aortocoronary bypass surgery. Am Heart J 123: 37–45, 1992

    PubMed  Google Scholar 

  21. Kato T, Wokalek H, Schöpf E, Eggert H, Ernst M, Rietchel ET, Fischer H: Measurement of chemiluminescence in freshly drawn human blood. Klin Wochencher 59: 203–211, 1981

    Google Scholar 

  22. Prasad K, Kalra J, Chaudhary AK, Debnath D: Effect of polymorphonuclear leukocyte-derived oxygen free radicals and hypochlorous acid on cardiac function and some biochemical parameters. Am Heart J 119: 538–550, 1990

    PubMed  Google Scholar 

  23. Barroso-Aranda J, Schmid-Schönbein GW: Transformation of neutrophils as indicator of irreversibility in hemorrhagic shock. Am J Physiol 257: H846-H852, 1989

    PubMed  Google Scholar 

  24. Zweier JL, Kuppusamy P, Lutty GA: Measurement of endothelial cell free radical generation: Evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 85: 4046–4050, 1988

    PubMed  Google Scholar 

  25. Park BH, Fikrig SM, Smithwick EM: Infection and nitroblue-tetrazolium reduction by neutrophils. Lancet 2: 532–534, 1968

    PubMed  Google Scholar 

  26. Prasad K, Kalra J: Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 125: 958–973, 1993

    PubMed  Google Scholar 

  27. Holt ME, Ryall MET, Campbell AK: Albumin inhibits human polymorphonuclear leukocyte luminol-dependent chemiluminescence: Evidence for oxygen free radical scavenging. Brit J Exptl Pathol 65: 231–241, 1984

    Google Scholar 

  28. DeChatelet CR, Shirley PS: Evaluation of chronic granulomatous diseases by a chemiluminescent assay of microlitre quantities of whole blood. Clin Chem 27: 1739–1741, 1981

    PubMed  Google Scholar 

  29. Tono-Oko T, Ueno N, Matsumoto T: Chemiluminescence of whole blood. I. A simple and rapid method for the estimation of phagocytic function of granulocytes and opsonic activity in whole blood. Clin Immunol Immunopathol 26: 66–75, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prasad, K., Kapoor, R. & Lee, P. Purpurogallin, a scavenger of polymorphonuclear leukocyte-derived oxyradicals. Mol Cell Biochem 139, 27–32 (1994). https://doi.org/10.1007/BF00944200

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00944200

Key words

Navigation